dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Bradbury Lobato, Melissa |
dc.contributor.author | Borràs, Eva |
dc.contributor.author | Perez Benavente, Maria Asuncion |
dc.contributor.author | Gil Moreno, Antonio |
dc.contributor.author | Santamaria Margalef, Anna |
dc.contributor.author | Sabidó, Eduard |
dc.date.accessioned | 2021-12-07T12:27:56Z |
dc.date.available | 2021-12-07T12:27:56Z |
dc.date.issued | 2021-05 |
dc.identifier.citation | Bradbury M, Borràs E, Pérez-Benavente A, Gil-Moreno A, Santamaria A, Sabidó E. Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients: A Mini-Review. Cancers. 2021 May;13:2067. |
dc.identifier.issn | 2072-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/6657 |
dc.description | Teixit cancerígen; Càncer d'ovaris; Proteòmica |
dc.description.sponsorship | This work was supported by the PhD4MD collaborative research program between the Vall d’Hebron Research Institute (VHIR) and the Centre for Genomic Regulation (CRG). The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17/0019 of the PE I + D + i 2013–2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF. We acknowledge support from the Spanish Ministry of Science and Innovation (CTQ2016-80364-P) and “Centro de Excelencia Severo Ochoa 2013–2017”, SEV-2012-0208; the “Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya” (2017SGR595 and 2017SGR1661), from the Instituto de Salud Carlos III (PI15/02238, PI18/01017, CPII18/00027) and from the Ministerio de Economia y Competitividad y Fondos FEDER (RTC-2015-3821). We also acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cancers;13 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Ovaris - Càncer -Tractament |
dc.subject | Proteòmica |
dc.subject.mesh | Ovarian Neoplasms |
dc.subject.mesh | /therapy |
dc.subject.mesh | Proteomics |
dc.title | Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients: A Mini-Review |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cancers13092067 |
dc.subject.decs | neoplasias ováricas |
dc.subject.decs | /terapia |
dc.subject.decs | proteómica |
dc.relation.publishversion | https://doi.org/10.3390/cancers13092067 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Bradbury M] Centre de Regulació Genòmica, Barcelona Institute of Science and Technology (BIST), Dr Aiguader 88, 08003 Barcelona, Spain. Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Dr Aiguader 88, 08003 Barcelona, Spain. Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Unitat d'Oncologia Ginecològica, Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Borràs E, Sabidó E] Centre de Regulació Genòmica, Barcelona Institute of Science and Technology (BIST), Dr Aiguader 88, 08003 Barcelona, Spain. Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Dr Aiguader 88, 08003 Barcelona, Spain. [Pérez-Benavente A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Unitat d'Oncologia Ginecològica, Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Gil-Moreno A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Unitat d'Oncologia Ginecològica, Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red (CIBERONC), Instituto de Salud Carlos III, Avenida de Monforte de Lemos 3-5, 28029 Madrid, Spain. [Santamaria A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Laboratori de Cicle Cel·lular i Càncer, Grup de Recerca Biomèdica en Urologia, Vall Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 33922979 |
dc.identifier.pmid | 000649865900001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CTQ2016-80364-P |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F02238 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F01017 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CPII18%2F00027 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/RTC-2015-3821 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |